Henry M. Jackson Foundation for the Advancement of Military Medicine

The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing. 

PrimeraDx, a Mansfield, Mass.-based molecular diagnostics firm, is on track to submit its highly multiplexed PCR-based testing system and associated assay for Clostridium difficile to the US Food and Drug Administration this quarter, CEO Matt McManus said recently.

NEW YORK (GenomeWeb News) – The Rutgers Cell and DNA Repository, or RUCDR, has landed a $2.4 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study mental health risk among service men and women.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.